Department of Urology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
BJU Int. 2022 Oct;130(4):470-477. doi: 10.1111/bju.15757. Epub 2022 May 17.
To evaluate the associations of peri-operative neutrophil-to-lymphocyte ratio (NLR) and change in NLR with survival after radical cystectomy.
We retrospectively reviewed a multicentre cohort of patients with bladder cancer who underwent radical cystectomy between 2010 and 2020. Preoperative NLR, postoperative NLR, delta-NLR (postoperative minus preoperative NLR) and NLR change (postoperative divided by preoperative NLR) were calculated. Patients were stratified based on elevation of preoperative and/ or postoperative NLR above the median values. Multivariable Cox regression models were used to evaluate the associations of peri-operative NLR and NLR change with survival.
The study cohort included 346 patients with a median age of 69 years. The median (interquartile range) preoperative NLR, postoperative NLR, delta-NLR and NLR change were 2.55 (1.83, 3.90), 3.33 (2.21, 5.20), 0.43 (-0.50, 2.08) and 1.2 (0.82, 1.96), respectively. Both preoperative and postoperative NLR were elevated in 110 patients (32%), 126 patients (36%) had an elevated preoperative or postoperative NLR, and 110 patients (32%) did not have an elevated NLR. On multivariable analysis, increased preoperative and postoperative NLR were significantly associated with decreased survival. While delta-NLR and NLR change were not associated with outcome, patients with elevations in both preoperative and postoperative NLR had the worst overall (hazard ratio [HR] 2.97, 95% confidence interval [CI] 1.78, 4.95; P < 0.001) and cancer-specific survival rates (HR 2.41, 95% CI 1.3, 4.4; P = 0.004).
Preoperative and postoperative NLR are significant predictors of survival after radical cystectomy; patients in whom both NLR measures were elevated had the worst outcomes. Future studies should evaluate whether an increase in NLR during long-term follow-up may precede disease recurrence.
评估围手术期中性粒细胞与淋巴细胞比值(NLR)及其变化与根治性膀胱切除术患者生存的关系。
我们回顾性分析了 2010 年至 2020 年间接受根治性膀胱切除术的膀胱癌患者多中心队列。计算术前 NLR、术后 NLR、NLR 差值(术后值减去术前值)和 NLR 变化(术后值除以术前值)。根据术前和/或术后 NLR 高于中位数将患者分为 NLR 升高组。多变量 Cox 回归模型用于评估围手术期 NLR 和 NLR 变化与生存的关系。
研究队列包括 346 名中位年龄为 69 岁的患者。中位(四分位间距)术前 NLR、术后 NLR、NLR 差值和 NLR 变化分别为 2.55(1.83,3.90)、3.33(2.21,5.20)、0.43(-0.50,2.08)和 1.2(0.82,1.96)。术前和术后 NLR 均升高的患者有 110 例(32%),术前或术后 NLR 升高的患者有 126 例(36%),NLR 无升高的患者有 110 例(32%)。多变量分析显示,术前和术后 NLR 升高与生存时间缩短显著相关。而 NLR 差值和 NLR 变化与结局无关,但术前和术后 NLR 均升高的患者总生存(风险比 [HR] 2.97,95%置信区间 [CI] 1.78,4.95;P <0.001)和癌症特异性生存(HR 2.41,95% CI 1.3,4.4;P =0.004)率最差。
术前和术后 NLR 是根治性膀胱切除术后生存的重要预测因素;这两个 NLR 指标均升高的患者预后最差。未来的研究应评估长期随访期间 NLR 增加是否可能先于疾病复发。